PerkinElmer U.S. LLC

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40007322

Informations générales

Localisation

United States of America

Northern America

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

12/06/2025

Objectifs à court terme (Near-Term)

Engagement de réduction des émissions à horizon 2034

Statut

Targets set

Classification

1.5°C

Année cible

2034

Progression vers l'objectif58%

2015 (année de référence)2034

Description complète des objectifs

Near-Term Targets: PerkinElmer commits to reduce absolute scope 1 GHG emissions 58.8% by 2034 from a 2023 base year. PerkinElmer also commits to increase active annual sourcing of renewable electricity from 0% in 2023 to 100% by 2030. PerkinElmer further commits to reduce scope 3 GHG emissions 63.8% per USD value added by 2034 from a 2023 base year.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

LEI

549300IKL1SDPFI7N655

Source : Science Based Targets initiative | Données publiques